Showing results (1-10 of 342) with videos related to
Sort By:
Pageof 35
Expert Review of Hematology|March 24, 2021
Hematological manifestations and complications of Gaucher diseaseShoshana Revel-Vilk, Jeff Szer, Ari ZimranBritish Journal of Haematology|May 30, 2018
How we manage Gaucher Disease in the era of choicesShoshana Revel-Vilk, Jeff Szer, Atul Mehta, et al.International Journal of Molecular Sciences|February 13, 2025
Preimplantation Genetic Testing (PGT) to Reduce the Risk for GBA-Related Parkinson's Disease: Expanding the Applications for Embryo SelectionShachar Zuckerman, Ari Zimran, Jeff Szer, et al.International Journal of Molecular Sciences|April 13, 2023
High-Dose Ambroxol Therapy in Type 1 Gaucher Disease Focusing on Patients with Poor Response to Enzyme Replacement Therapy or Substrate Reduction TherapyMajdolen Istaiti, Dafna Frydman, Tama Dinur, et al.Journal of Clinical Medicine|March 29, 2023
The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement TherapyAri Zimran, Jeff Szer, Michal Becker-Cohen, et al.Orphanet Journal of Rare Diseases|October 14, 2020
Patient reported outcome measures in a large cohort of patients with type 1 Gaucher diseaseTama Dinur, Majdolen Istaiti, Dafna Frydman, et al.Biologics : Targets & Therapy|September 24, 2009
Review of the safety and efficacy of imiglucerase treatment of Gaucher diseaseDeborah Elstein, Ari ZimranPediatric Endocrinology Reviews : PER|October 28, 2014
Management of Gaucher disease: enzyme replacement therapyAri Zimran, Deborah ElsteinPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 14, 2003
Gaucher disease and the clinical experience with substrate reduction therapyAri Zimran, Deborah ElsteinPageof 35